or Try an Advanced Search...

    Technical Analysis for SLDB - Solid Biosciences Inc.

    Grade Last Price % Change Price Change
    D 8.98 5.15% 0.44
    SLDB closed up 5.15 percent on Friday, April 26, 2024, on 74 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 9
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical SLDB trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish 5.15%
    Lizard Bullish Bullish Day Trade Setup 5.15%
    Doji - Bullish? Reversal 5.15%
    Wide Bands Range Expansion 5.15%
    Gapped Down Weakness 5.15%
    Oversold Stochastic Weakness 5.15%
    Wide Bands Range Expansion 2.39%
    Older End-of-Day Signals for SLDB ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 17 hours ago
    Possible NR7 about 17 hours ago
    60 Minute Opening Range Breakout about 18 hours ago
    Lizard Bullish Entry about 22 hours ago
    Hammer Candlestick Entry about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SLDB Chart by TradingView
    Basic chart:

    Profile

    Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Cytoskeleton Dystrophin

    Is SLDB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 10 Buy Solid Biosciences: Unpacking Its Main Value Driver
    Apr 3 Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Apr 2 Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
    Apr 1 Solid Biosciences gets FDA rare pediatric disease status for DMD therapy
    Apr 1 Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
    Mar 28 How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
    Mar 28 William Blair starts Solid Biosciences at outperform
    Mar 27 Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium
    Mar 15 Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
    Mar 13 Piper Sandler upgrades Solid Biosciences to overweight
    See more SLDB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.05
    52 Week Low 1.81
    Average Volume 255,584
    200-Day Moving Average 5.95
    50-Day Moving Average 10.99
    20-Day Moving Average 10.46
    10-Day Moving Average 9.22
    Average True Range 0.85
    RSI (14) 36.71
    ADX 23.56
    +DI 17.13
    -DI 31.29
    Chandelier Exit (Long, 3 ATRs) 12.49
    Chandelier Exit (Short, 3 ATRs) 10.51
    Upper Bollinger Bands 13.25
    Lower Bollinger Band 7.67
    Percent B (%b) 0.24
    BandWidth 53.33
    MACD Line -0.78
    MACD Signal Line -0.54
    MACD Histogram -0.2394
    Fundamentals Value
    Market Cap 336.2 Million
    Num Shares 37.4 Million
    EPS 73.71
    Price-to-Earnings (P/E) Ratio 0.12
    Price-to-Sales 11.89
    Price-to-Book 2.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.99
    Resistance 3 (R3) 9.91 9.49 9.82
    Resistance 2 (R2) 9.49 9.24 9.53 9.76
    Resistance 1 (R1) 9.24 9.08 9.37 9.32 9.71
    Pivot Point 8.82 8.82 8.89 8.86 8.82
    Support 1 (S1) 8.57 8.57 8.70 8.65 8.25
    Support 2 (S2) 8.15 8.41 8.19 8.20
    Support 3 (S3) 7.90 8.15 8.14
    Support 4 (S4) 7.98